RCT to Evaluate Outpatient Treatment for Adolescents with Substance Use and Internalizing Disorders
A randomized clinical trial will compare a new psychosocial treatment for adolescents with co-occurring substance use and internalizing disorders against an active placebo.
Phase III
Psychiatry / Substance Use Disorders
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing randomized clinical trial aims to establish a new psychosocial treatment standard for adolescents with dual diagnoses, which could significantly shift treatment protocols and market dynamics. Successful outcomes may necessitate strategic adaptations for companies involved in adolescent mental health therapies.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor the trial results and any subsequent publications that may influence treatment guidelines and market opportunities in adolescent psychiatry.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.